). In accordance with this interpretation, inSummary creased PtdIns5P production was seen when cellular levels of PtdIns(3,5)P 2 were increased following osmotic Phosphoinositides control many different processes shock ( Figure 1C ; [ 
tubularins [17] . While unusual, there are a number of monomeric enzymes displaying allosteric regulation [18] , such as the ribonucleotide reductase of Lactobacillus leichmannii that has a catalytic site where ribonucleotides bind and a discrete regulatory site for nucleotides [19, 20] . To explain the sigmoidal curves of initial velocity as a function of substrate concentration for MTM1, we initially postulated that the substrate, PtdIns3P, is a weak allosteric activator capable of binding at a regulatory site on the monomeric enzyme. By analogy with ribonucleotide reductase, we felt it was unlikely that PtdIns3P was the physiological activator, but that this could be a related molecule. Non-substrate phosphoinositides were therefore tested for their ability to activate MTM1. The activity of MTM1 toward 50 M PtdIns3P was stimulated by 20 M PtdIns5P, while PtdIns4P had no effect, and the other phosphoinositides tested had little or an inhibitory effect ( Figure S3A ). PtdIns5P activates the catalytic activity of MTM1 toward both PtdIns3P and PtdIns(3,5)P 2 ( Figures 2C and 2D) . Additionally, the effect of PtdIns5P on PtdIns3P hydrolysis by MTM1 was also observed when long chain derivatives of these phosphoinositides were incorporated into liposomes ( Figure 2E ). Likewise, the activity of MTMR3 toward 50 M PtdIns3P was activated in the presence of 20 M PtdIns5P (Figure 2F ), while, under the same conditions, the initial rate of reaction was increased for MTMR6 although the sustained reaction velocity at later time points was similar ( Figure S3B ). It is important to note that PtdIns5P is not a substrate for these enzymes (Figure 1; [10] ), and we conclude that it acts as an allosteric activator for MTM1, MTMR3, and possibly MTMR6. When PtdIns(3,5)P 2 is used as the substrate, PtdIns5P is generated and could activate the enzyme by a positive feedback mechanism. It is unlikely that such a regulatory mechanism would exist to no effect, and this finding supports the proposition that PtdIns(3,5)P 2 represents a physiologically relevant substrate for myotubularins. In addition to localization to membrane subcompartments such as plasma membrane ruffles [21] , myotubularin activity could also be compartmentalized by the availability of PtdIns5P. Thus, PtdIns3P and PtdIns(3,5)P 2 in membrane domains lacking PtdIns5P would be poor substrates for myotubularins.
During our investigations of MTM1, MTMR3, and MTMR6, we noticed that their catalytic activity showed a sigmoidal dependence on enzyme concentration, suggestive of oligomerization under reaction conditions. MTM1 shows a 9-fold increase in initial reaction velocity toward PtdIns3P when enzyme concentration is increased from 15 to 30 nM ( Figure 3A) . To investigate the potential oligomerization of MTM1 under reaction conditions, we exploited the fact that mutations in the catalytic cysteine of phosphatases are thought to abolish catalytic activity without altering their substrate binding properties [14] . First, the activity of 30 nM MTM1 found to lack activity toward PtdIns3P, even in the presinteracts with MTM1 C375S in the presence of substrate and that these oligomeric forms of the enzyme have ence of PtdIns5P ( Figure 3B ). To shift the equilibrium from monomeric to oligomeric MTM1, catalytically dead increased activity compared to monomeric MTM1. To visualize these oligomeric forms of MTM1, we analyzed MTM1 C375S was titrated into assays containing 18 nM MTM1, a concentration at which MTM1 shows approxienzyme reactions by negative stain electron microscopy ( Figure 3D ). Catalytically inactive MTM1 C375S was used mately half maximal activity toward PtdIns3P and is thus poised for activation ( Figure 3A ). The addition of 1.8 nM for these experiments to trap the substrate and activator bound intermediates, since these are rapidly turned over MTM1 C375S caused an increase in the activity of MTM1, and this effect was already maximal when equimolar by the active enzyme. This analysis revealed that, under activated conditions, MTM1 forms a heptameric ring MTM1 C375S was used ( Figure 3C ). When MTM1 C375S was replaced by catalytically inactive MTMR6 or bovine sestructure that is on average 12.5 nm in diameter, and that these ring structures are essentially absent prior rum albumin, these effects were not seen, indicating that this is a specific effect of MTM1 ( Figure S4 ). The to activation of MTM1 with PtdIns5P and substrate (Figure 3D) . simplest explanation for this observation is that MTM1 We then examined the sequence of MTM1 for conquires 50 M PtdIns5P to achieve the same level of activity ( Figure 4B ). This observation is consistent with served basic residues associated with disease-causing mutations in X-linked myotubular myopathy [22, 23] , the idea that MTM1 R69C shows a reduced level of activity due to a mutation in its allosteric regulatory site and which, by analogy with pleckstrin homology (PH) domains, could mediate the specific recognition of phoshas a reduced affinity for PtdIns5P. The amino-terminal region of myotubularins contains a divergent PH domain phoinositides [ 
